Patent · US Active

Antibody for binding to interleukin 4 receptor

US10774141B2 · kind B2 · utility

1Cited by

2References

25Claims

0Family size

Assignee

SuZhou Connect Biopharmaceuticals, Inc. · CN

Inventors

Wei Zheng · Rockville, US
Wubin PAN · Richmond, CA
Xin Yang · 浮桥镇, CN
Yang Chen · Ambler, US
Limin Zhang · Beijing, CN
Jie Jiang · Atlanta, US

Key dates

Filing date	Mar 4, 2020
Grant date	Sep 15, 2020
Priority date	—
Expiry date	Mar 4, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2015/8518
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed is an antibody capable of binding to the interleukin 4 (IL-4) receptor (IL-4). Also disclosed are a nucleic acid sequence encoding the antibody, a vector including the nucleic acid sequence, and a host cell transformed or transfected with the vector. Provided are a method for producing the antibody, a medical use of the antibody, and a kit including the antibody.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.